Establishment of TUSMi008-A, an induced pluripotent stem cell (iPSC) line from a 76-year old Alzheimer's disease (AD) patient with PAXIP1 gene mutation

Ying Wang; Jing Zhang; Jinghua Hu; Gang Li; Ying Lei; Jian Zhao

doi:10.1016/j.scr.2019.101391

Establishment of TUSMi008-A, an induced pluripotent stem cell (iPSC) line from a 76-year old Alzheimer's disease (AD) patient with PAXIP1 gene mutation

Ying Wang, Jing Zhang, Jinghua Hu, Gang Li, Ying Lei, Jian Zhao

Biochemistry and Molecular Biology

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

A 76-year old Alzheimer's disease (AD) female patient donated her Peripheral blood mononuclear cells (PBMC). The non-integrating episomal vector system used to reprogram PBMCs with the human OKSM transcription factors. The pluripotency of transgene-free iPSCs was confirmed by immunocytochemistry for pluripotency markers and by the ability of the iPSCs to differentiate spontaneously into 3 germ layers in vitro. In addition, the iPSC line displayed a normal karyotype. Our model might offer a good platform to further study the pathological mechanisms, to identify early biomarkers, and also for drug testing studies in AD.

Original language	English (US)
Article number	101391
Journal	Stem Cell Research
Volume	36
DOIs	https://doi.org/10.1016/j.scr.2019.101391
State	Published - Apr 2019

ASJC Scopus subject areas

Developmental Biology
Cell Biology

Access to Document

10.1016/j.scr.2019.101391

Cite this

@article{722e5ef07d7841f6b0ee8f661e9b2dd3,

title = "Establishment of TUSMi008-A, an induced pluripotent stem cell (iPSC) line from a 76-year old Alzheimer's disease (AD) patient with PAXIP1 gene mutation",

abstract = "A 76-year old Alzheimer's disease (AD) female patient donated her Peripheral blood mononuclear cells (PBMC). The non-integrating episomal vector system used to reprogram PBMCs with the human OKSM transcription factors. The pluripotency of transgene-free iPSCs was confirmed by immunocytochemistry for pluripotency markers and by the ability of the iPSCs to differentiate spontaneously into 3 germ layers in vitro. In addition, the iPSC line displayed a normal karyotype. Our model might offer a good platform to further study the pathological mechanisms, to identify early biomarkers, and also for drug testing studies in AD.",

author = "Ying Wang and Jing Zhang and Jinghua Hu and Gang Li and Ying Lei and Jian Zhao",

note = "Publisher Copyright: {\textcopyright} 2019 The Authors",

year = "2019",

month = apr,

doi = "10.1016/j.scr.2019.101391",

language = "English (US)",

volume = "36",

journal = "Stem Cell Research",

issn = "1873-5061",

publisher = "Elsevier",

}

TY - JOUR

T1 - Establishment of TUSMi008-A, an induced pluripotent stem cell (iPSC) line from a 76-year old Alzheimer's disease (AD) patient with PAXIP1 gene mutation

AU - Wang, Ying

AU - Zhang, Jing

AU - Hu, Jinghua

AU - Li, Gang

AU - Lei, Ying

AU - Zhao, Jian

PY - 2019/4

Y1 - 2019/4

N2 - A 76-year old Alzheimer's disease (AD) female patient donated her Peripheral blood mononuclear cells (PBMC). The non-integrating episomal vector system used to reprogram PBMCs with the human OKSM transcription factors. The pluripotency of transgene-free iPSCs was confirmed by immunocytochemistry for pluripotency markers and by the ability of the iPSCs to differentiate spontaneously into 3 germ layers in vitro. In addition, the iPSC line displayed a normal karyotype. Our model might offer a good platform to further study the pathological mechanisms, to identify early biomarkers, and also for drug testing studies in AD.

AB - A 76-year old Alzheimer's disease (AD) female patient donated her Peripheral blood mononuclear cells (PBMC). The non-integrating episomal vector system used to reprogram PBMCs with the human OKSM transcription factors. The pluripotency of transgene-free iPSCs was confirmed by immunocytochemistry for pluripotency markers and by the ability of the iPSCs to differentiate spontaneously into 3 germ layers in vitro. In addition, the iPSC line displayed a normal karyotype. Our model might offer a good platform to further study the pathological mechanisms, to identify early biomarkers, and also for drug testing studies in AD.

UR - http://www.scopus.com/inward/record.url?scp=85062225015&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062225015&partnerID=8YFLogxK

U2 - 10.1016/j.scr.2019.101391

DO - 10.1016/j.scr.2019.101391

M3 - Article

C2 - 30831521

AN - SCOPUS:85062225015

SN - 1873-5061

VL - 36

JO - Stem Cell Research

JF - Stem Cell Research

M1 - 101391

ER -

Establishment of TUSMi008-A, an induced pluripotent stem cell (iPSC) line from a 76-year old Alzheimer's disease (AD) patient with PAXIP1 gene mutation

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this